LACTB2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.356640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.123800E-01
Normal-vs-Stage2
1.121010E-01
Normal-vs-Stage3
5.169400E-01
Normal-vs-Stage4
1.399550E-01
Stage1-vs-Stage2
5.262800E-01
Stage1-vs-Stage3
1.736600E-01
Stage1-vs-Stage4
4.404600E-01
Stage2-vs-Stage3
1.992750E-01
Stage2-vs-Stage4
6.462400E-01
Stage3-vs-Stage4
3.968000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.445210E-01
Normal-vs-AfricanAmerican
1.808420E-01
Normal-vs-Asian
2.214400E-01
Caucasian-vs-AfricanAmerican
8.922600E-01
Caucasian-vs-Asian
8.973000E-01
AfricanAmerican-vs-Asian
9.781200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.395820E-01
Normal-vs-Female
1.427850E-01
Male-vs-Female
8.349000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.508200E-01
Normal-vs-Age(41-60Yrs)
1.063040E-01
Normal-vs-Age(61-80Yrs)
1.773030E-01
Normal-vs-Age(81-100Yrs)
6.298300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.507400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.309000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.614200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.344500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.400800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.056400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.237380E-01
Normal-vs-Daily Drinker
3.001000E-01
Normal-vs-Weekly Drinker
4.074200E-01
Normal-vs-Occasional Drinker
5.191900E-02
Normal-vs-Social Drinker
3.577500E-02
Non Drinker-vs-Daily Drinker
6.404200E-01
Non Drinker-vs-Weekly Drinker
4.010300E-02
Non Drinker-vs-Occasional Drinker
3.019000E-01
Non Drinker-vs-Social Drinker
8.754000E-01
Daily Drinker-vs-Weekly Drinker
1.432770E-01
Daily Drinker-vs-Occasional Drinker
7.646800E-01
Daily Drinker-vs-Social Drinker
7.454200E-01
Weekly Drinker-vs-Occasional Drinker
7.778200E-02
Weekly Drinker-vs-Social Drinker
2.133800E-02
Occasional Drinker-vs-Social Drinker
3.656000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.929000E-01
Normal-vs-Grade 2
5.888000E-02
Normal-vs-Grade 3
5.987800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.349900E-02
Grade 1-vs-Grade 3
2.230100E-02
Grade 1-vs-Grade 4
1.929000E-01
Grade 2-vs-Grade 3
7.027000E-01
Grade 2-vs-Grade 4
5.888000E-02
Grade 3-vs-Grade 4
5.987800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.130400E-01
Normal-vs-NonDiabetic
1.333610E-01
Diabetic-vs-NonDiabetic
8.557400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.233700E-02
Normal-vs-NoPancreatitis
1.492430E-01
Pancreatitis-vs-NoPancreatitis
9.432400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.607650E-01
Normal-vs-N1
1.160200E-01
N0-vs-N1
2.963400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.21759999988691E-07
Normal-vs-TP53-NonMutant
1.617630E-03
TP53-Mutant-vs-TP53-NonMutant
1.779400E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
